Screener
Candel Therapeutics, Inc. CADL Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
| Line item | MARCH 31,2026(Unaudited) | DECEMBER 31,2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value; 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued or outstanding at March 31, 2026 and December 31, 2025. | — | — |
| Common stock, $0.01 par value; 150,000,000 shares authorized at March 31, 2026 and December 31, 2025; 73,380,472 and 55,020,911 shares issued at March 31, 2026 and December 31, 2025, respectively; 73,257,864 and 54,898,303 shares outstanding at March 31, 2026 and December 31, 2025, respectively. | 733 | 550 |
| Treasury stock (at cost) | (448) | (448) |
| Additional paid-in capital | 376,992 | 282,207 |
| Accumulated deficit | (239,248) | (230,387) |
| Total stockholders’ equity | 138,029 | 51,922 |
| Total liabilities and stockholders’ equity | $201,920 | $125,195 |
Item 1. Financial Statements.
FAQ
- What is Candel Therapeutics, Inc.'s total equity?
- Candel Therapeutics, Inc. (CADL) reported total equity of $138.03M in Q1 2026.
- How has Candel Therapeutics, Inc.'s total equity changed year-over-year?
- Candel Therapeutics, Inc.'s total equity increased by 84.8% year-over-year, from $74.68M to $138.03M.
- What is the long-term trend for Candel Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s total equity has grown at a 17.1% compound annual growth rate (CAGR), from -$23.56M to $51.92M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Candel Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude